8-K: Sleep Number Reports Q1 2024 Results: EBITDA Exceeds Expectations Amidst Sales Decline

Sleep Number's first quarter results show adjusted EBITDA slightly ahead of expectations despite an 11% year-over-year sales decline, driven by cost reductions and improved operating efficiencies.

Summary

• Sleep Number reported net sales of $470 million for the first quarter of 2024, an 11% decrease compared to the same period last year, with approximately 4 percentage points of the decline attributed to changes in order backlog.
• The company's gross margin was 58.7%, slightly down from 58.9% in the prior year, but showed a significant sequential improvement from the second half of the previous year.
• Operating expenses were reduced by $24 million year-over-year to $260 million before restructuring charges.
• Adjusted EBITDA for the quarter was $37 million, compared to $49 million in the prior year, but slightly exceeded expectations due to cost reduction efforts.
• Free cash flow increased significantly to $24 million, up from $3 million in the same quarter last year.
• The company is reiterating its full-year 2024 adjusted EBITDA outlook of $125 million to $145 million and expects a mid-single digit net sales decline for the year.
• Sleep Number anticipates approximately 100 basis points of gross margin rate improvement and $14 million in restructuring charges for the year.
• The company expects to generate $60 million to $80 million of free cash flow with capital expenditures of $30 million.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive. While sales declined, the company exceeded EBITDA expectations, significantly increased free cash flow, and is actively reducing costs and debt. The reiteration of full-year guidance provides stability, but the sales decline and economic risks temper the overall outlook.

Positives

• The company exceeded expectations for adjusted EBITDA in the first quarter.
• Significant year-over-year increase in free cash flow was achieved.
• Operating expenses were substantially reduced, demonstrating effective cost management.
• The company is prioritizing paying down debt and reducing leverage.
• Gross margin rate showed a significant sequential improvement from the back-half of the prior year.
• The company is on track to deliver $40 million to $45 million of operating expense reductions for the year.

Negatives

• Net sales declined by 11% year-over-year, including pressure from order backlog changes.
• Adjusted EBITDA decreased compared to the same quarter last year, although it was still ahead of expectations.
• The company expects a mid-single digit net sales decline for the full year.

Risks

• The company faces risks related to changes in economic conditions and consumer sentiment, which could impact discretionary spending.
• Increases in interest rates could increase the cost of servicing the company's debt.
• The company is dependent on key suppliers and third parties, and disruptions in these relationships could impact operations.
• Fluctuations in commodity costs, third-party delivery costs, and other inflationary pressures could affect profitability.
• Global sourcing activities carry risks including tariffs, foreign regulations, geopolitical issues, and supply chain disruptions.
• Operating with minimal inventory levels could make the company vulnerable to supply shortages.
• The company faces risks related to cyber threats, data breaches, and disruptions to information systems.
• The company's ability to compete effectively and protect its intellectual property is crucial.
• The company is exposed to environmental, social, and governance risks, including climate change and regulatory responses.

Future Outlook

The company reiterates its full-year 2024 adjusted EBITDA outlook of $125 million to $145 million and expects a mid-single digit net sales decline for the year. They also anticipate approximately 100 basis points of gross margin rate improvement and $60 million to $80 million of free cash flow.

Management Comments

• Shelly Ibach, Chair, President and CEO, stated that actions to increase operating model efficiencies drove first quarter adjusted EBITDA and gross margin rate ahead of expectations.
• She also mentioned the company generated a significant year-over-year increase in free cash flow and continues to prioritize paying down debt and reducing leverage.
• Management expects to capitalize on the company's significant opportunity as a sleep wellness technology company as demand for the category improves from recessionary levels.

Industry Context

The results reflect a challenging environment for consumer discretionary spending, with the company noting recessionary levels impacting demand. However, the focus on cost reduction and efficiency improvements aligns with broader industry trends of companies seeking to optimize operations in the current economic climate. The company's emphasis on sleep wellness technology also positions it to capitalize on the growing health and wellness market.

Comparison to Industry Standards

• While Sleep Number's Q1 sales declined by 11%, this is not uncommon in the current economic climate for companies in the consumer discretionary sector. For example, Tempur Sealy International, a major competitor, has also faced challenges in sales growth, although specific Q1 results would need to be compared directly when released.
• Sleep Number's focus on direct-to-consumer sales and technology integration is a differentiator compared to traditional mattress retailers. Companies like Purple Innovation also focus on technology and direct sales, but their financial performance and market positioning differ.
• The company's adjusted EBITDA of $37 million, while down year-over-year, is a positive sign given the sales decline, indicating effective cost management. This is a key metric that investors will compare to peers like Casper Sleep, which has struggled with profitability.
• The increase in free cash flow to $24 million is a strong positive, demonstrating the company's ability to generate cash despite sales headwinds. This is a critical metric for investors, especially when compared to companies with high debt levels or negative cash flow.

Stakeholder Impact

• Shareholders may be cautiously optimistic due to the better-than-expected EBITDA and increased free cash flow, but concerned about the sales decline.
• Employees may be impacted by restructuring efforts and cost-cutting measures.
• Customers may benefit from the company's focus on product quality and innovation.
• Suppliers and creditors may be impacted by the company's efforts to reduce costs and debt.

Next Steps

• Management will host a conference call to discuss the results.
• The company will continue to focus on cost reductions and improving operating efficiencies.
• The company will continue to prioritize paying down debt and reducing leverage.
• The company will continue to execute its Total Retail distribution strategy.

Key Dates

Keywords

Sleep Number, EBITDA, Free Cash Flow, Net Sales, Operating Expenses, Gross Margin, Restructuring, Debt Reduction, Leverage, Wellness Technology